Published in J Clin Invest on February 01, 1978
Distinction between epidermal antigens binding pemphigus vulgaris and pemphigus foliaceus autoantibodies. J Clin Invest (1984) 1.92
Pemphigus antibodies identify a cell surface glycoprotein synthesized by human and mouse keratinocytes. J Clin Invest (1982) 1.90
The desmosome and pemphigus. Histochem Cell Biol (2008) 1.54
Identification of pemphigus vulgaris antigen extracted from normal human epidermis and comparison with pemphigus foliaceus antigen. J Clin Invest (1988) 1.37
Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases. J Clin Invest (1989) 1.26
Further analysis of pemphigus autoantibodies and their use in studies on the heterogeneity, structure, and function of desmosomes. J Cell Biol (1986) 1.20
Complement fixation by Brazilian Pemphigus foliaceus autoantibodies. Clin Exp Immunol (1988) 0.81
Role of plasminogen activator in pemphigus vulgaris. Am J Pathol (1989) 0.79
Distinguishing the antigen specificities of pemphigus vulgaris and pemphigus foliaceus using the biotin-avidin immunofluorescence method. Arch Dermatol Res (1987) 0.75
Avidin-biotin-peroxidase complex immunohistochemistry to detect immunoglobulin in formalin fixed skin biopsies in canine autoimmune skin disease. Can J Vet Res (1987) 0.75
DEMONSTRATION OF SKIN ANTIBODIES IN SERA OF PEMPHIGUS VULGARIS PATIENTS BY INDIRECT IMMUNOFLUORESCENT STAINING. Proc Soc Exp Biol Med (1964) 3.73
AUTOANTIBODIES IN PEMPHIGUS VULGARIS: RESPONSE TO AN INTERCELLULAR SUBSTANCE OF EPIDERMIS. JAMA (1965) 2.27
The immunopathology of pemphigus and bullous pemphigoid. J Invest Dermatol (1968) 2.17
Production of epidermal acantholysis in normal human skin in vitro by the IgG fraction from pemphigus serum. J Invest Dermatol (1976) 1.99
Clinical significance of autoantibodies in pemphigus. Arch Dermatol (1966) 1.95
Complement immunofluorescent staining in bullous pemphigoid. J Lab Clin Med (1969) 1.83
Direct immunofluorescent studies of pemphigus and bullous pemphigoid. Arch Dermatol (1971) 1.39
AN ELECTRON MICROSCOPIC STUDY OF ACANTHOLYSIS AND DYSKERATOSIS IN PEMPHIGUS FOLIACEUS: WITH A SPECIAL NOTE ON PECULIAR INTRACYTOPLASMIC BODIES. J Invest Dermatol (1964) 1.36
Complement activation in pemphigus vulgaris blister fluid. Clin Exp Immunol (1973) 1.27
Pemphigus foliaceus. Subcorneal intercellular antibodies of unique specificity. Arch Dermatol (1974) 1.20
Direct immunofluorescent study of the skin on occurrence of complement in pemphigus. Br J Dermatol (1972) 1.20
Factors contributing to occasional failures in demonstration of pemphigus antibodies by the immunofluorescence test. J Invest Dermatol (1969) 1.18
Studies in bullous diseases. Immunofluorescent serologic tests. N Engl J Med (1968) 1.17
An electron microscopic study on pemphigus vulgaris of the mouth and the skin with special reference to the intercellular cement. J Invest Dermatol (1967) 1.16
Correlation of pemphigoid and pemphigus antibody titres with activity of disease. Br J Dermatol (1971) 1.15
Classical and alternate pathway activation of complement in pemphigus vulgaris lesions. J Invest Dermatol (1974) 1.11
Immunofluorescent studies of autoantibodies to intercellular areas of epithelia in Brazilian pemphigus foliaceus. Proc Soc Exp Biol Med (1968) 0.99
Destruction of epithelial cells in vivo by antiepithelial autoantibodies. J Invest Dermatol (1967) 0.98
Antibodies against the cytoplasm of human epidermal cells. Arch Dermatol (1973) 0.98
[Anti-epidermal antibodies in bullous dermatoses. Clinical and experimental data]. Bull Soc Fr Dermatol Syphiligr (1967) 0.87
Indirect cutaneous immunofluorescence. I. Morphologic observations in bullous diseases, malignancies, and connective tissue diseases. Arch Dermatol (1972) 0.83
Studies in immunodermatology. II. Production of pemphigus-like lesions by intradermal injection of monkeys with Brazilian pemphigus foliaceus sera. Int Arch Allergy Appl Immunol (1972) 0.79
The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto VER. Arch Ophthalmol (2001) 3.31
Prognostic significance of hypopigmentation in malignant melanoma. Arch Dermatol (1987) 2.51
Cell wall composition of the yeast and mycelial forms of Paracoccidioides brasiliensis. J Bacteriol (1969) 2.50
Epidemiologic features of diabetes mellitus among Indians in northwestern Ontario and northeastern Manitoba. Can Med Assoc J (1985) 2.20
Diabetes and diabetic retinopathy in a Mexican-American population: Proyecto VER. Diabetes Care (2001) 2.16
Incidence of vitreoretinal pathologic conditions within 24 months after laser in situ keratomileusis. Ophthalmology (2000) 2.16
Primary hepatic lymphoma: favorable outcome after combination chemotherapy. Cancer (2001) 2.08
Immunofluorescence abnormalities in lichen planopilaris. Arch Dermatol (1992) 2.02
Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture. Shock (1995) 1.84
Role of ligaments and facets in lumbar spinal stability. Spine (Phila Pa 1976) (1995) 1.74
Regulation of antibody formation by serum antibody. II. Removal of specific antibody by means of exchange transfusion. J Exp Med (1970) 1.70
Food allergy in adulthood. Allergy (2003) 1.67
Dismantling cell-cell contacts during apoptosis is coupled to a caspase-dependent proteolytic cleavage of beta-catenin. J Cell Biol (1997) 1.60
Albendazole therapy for neurocysticercosis. Arch Intern Med (1987) 1.58
Serum soluble interleukin-2 receptor concentrations as an independent prognostic marker in head and neck cancer. Lancet (2001) 1.58
How, when, and why bile duct injury occurs. A comparison between open and laparoscopic cholecystectomy. Surg Endosc (1998) 1.57
Polarized gamma-ray emission from the galactic black hole Cygnus X-1. Science (2011) 1.56
Modulated high-energy gamma-ray emission from the microquasar Cygnus X-3. Science (2009) 1.55
Mycelial phase of Paracoccidioides brasiliensis and Blastomyces dermatitidis: an electron microscope study. J Bacteriol (1968) 1.55
Prognostic value of tumor regression during radiotherapy for head and neck cancer: a prospective study. Int J Radiat Oncol Biol Phys (1995) 1.52
ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma. Ann Oncol (2013) 1.51
Antibodies to normal human melanocytes in vitiligo. J Exp Med (1983) 1.50
T-cell-rich B large-cell lymphoma simulating lymphocyte-rich Hodgkin's disease. Am J Surg Pathol (1996) 1.42
Oncogene-dependent apoptosis is mediated by caspase-9. Proc Natl Acad Sci U S A (1998) 1.42
Ineffectiveness of cyclosporine as an adjuvant to corticosteroids in the treatment of pemphigus. Arch Dermatol (2000) 1.42
[First comparisons with laser vibrometry measurements and computer simulation of ear ossicle movements]. HNO (1997) 1.40
Mycoplasmal infections prevent apoptosis and induce malignant transformation of interleukin-3-dependent 32D hematopoietic cells. Mol Cell Biol (1999) 1.40
Serum levels of circulating intercellular adhesion molecule 1 in human malignant melanoma. Cancer Res (1991) 1.40
Induction chemotherapy in advanced head and neck tumors: results of two randomized trials. Int J Radiat Oncol Biol Phys (1992) 1.40
Association of tissue-fixed cytoplasmic deposits of immunoglobulin in epidermal keratinocytes with lupus erythematosus. Arch Dermatol (1993) 1.38
Identification of a 160-kD molecule as a component of the basement membrane zone and as a minor bullous pemphigoid antigen. J Invest Dermatol (1990) 1.36
Neurocytoma of spinal cord. Acta Neuropathol (1994) 1.25
Individualising gentamicin dosage regimens. A comparative review of selected models, data fitting methods and monitoring strategies. Clin Pharmacokinet (1991) 1.23
Psychometric properties of the 25-item NEI-VFQ in a Hispanic population: Proyecto VER. Invest Ophthalmol Vis Sci (2001) 1.21
Fusarium oxysporum endophthalmitis. Arch Ophthalmol (1979) 1.21
Treatment of chronic Chagas' disease with itraconazole and allopurinol. Am J Trop Med Hyg (1998) 1.21
Update on the evaluation of hypersensitivity reactions to betalactams. Allergy (2009) 1.21
Pemphigus foliaceus. Subcorneal intercellular antibodies of unique specificity. Arch Dermatol (1974) 1.20
Epidermolysis bullosa acquisita. Incidence in patients with basement membrane zone antibodies. Arch Dermatol (1990) 1.19
Effects of polychlorinated biphenyls (PCBs) on in vitro fertilization in the mouse. Reprod Toxicol (1994) 1.16
Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo. J Invest Dermatol (1991) 1.15
Penaeidins, a new family of antimicrobial peptides isolated from the shrimp Penaeus vannamei (Decapoda). J Biol Chem (1997) 1.15
Phylogenetic differentiation of two closely related Nitrosomonas spp. That inhabit different sediment environments in an oligotrophic freshwater lake. Appl Environ Microbiol (1999) 1.14
Automatic definition of recurrent local structure motifs in proteins. J Mol Biol (1990) 1.14
Reproductive toxicity of Aroclor-1254: effects on oocyte, spermatozoa, in vitro fertilization, and embryo development in the mouse. Reprod Toxicol (1995) 1.14
Comparison of alopecia areata in human and nonhuman mammalian species. Pathobiology (1998) 1.14
Portable microsensors based on individual SnO2 nanowires. Nanotechnology (2007) 1.13
Antibodies to hair follicles in alopecia areata. J Invest Dermatol (1994) 1.13
Properties and ontogenic development of membrane-bound histidine decarboxylase from rat brain. J Neurochem (1988) 1.13
Are desmoglein autoantibodies essential for the immunopathogenesis of pemphigus vulgaris, or just "witnesses of disease"? Exp Dermatol (2006) 1.13
Sepcific removal of in vivo antibody by extracorporeal circulation over an immunoadsorbent in gel. J Clin Invest (1971) 1.13
Crystal structure of Apaf-1 caspase recruitment domain: an alpha-helical Greek key fold for apoptotic signaling. J Mol Biol (1999) 1.13
A model to assess the usefulness of performance indicators. Int J Qual Health Care (1996) 1.12
Health service use by African Americans and Caucasians with asthma in a managed care setting. Am J Respir Crit Care Med (1998) 1.12
Melanoma and vitiligo are associated with antibody responses to similar antigens on pigment cells. Arch Dermatol (1995) 1.12
Coloanal anastomosis: are functional results better with a pouch? Dis Colon Rectum (1995) 1.11
Penaeidins, antimicrobial peptides with chitin-binding activity, are produced and stored in shrimp granulocytes and released after microbial challenge. J Cell Sci (2000) 1.07
Reproductive emergencies in camelids. Theriogenology (2008) 1.07
Epidermal cytoplasmic antibodies: incidence and type in normal persons and patients with melanoma. J Invest Dermatol (1976) 1.05
HLA-independent heterogeneity of CD8+ T cell responses to MAGE-3, Melan-A/MART-1, gp100, tyrosinase, MC1R, and TRP-2 in vaccine-treated melanoma patients. J Immunol (1998) 1.05
Regional variation in the expression of bullous pemphigoid antigen and location of lesions in bullous pemphigoid. J Invest Dermatol (1984) 1.04
Biocompatibility of a biodegradable in situ forming implant system in rhesus monkeys. J Biomed Mater Res (1999) 1.04
Patterns of remission in pemphigus vulgaris. J Am Acad Dermatol (2000) 1.04
Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: a prospective study. Radiology (1996) 1.03
Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity. J Invest Dermatol (1988) 1.02
Non-commercial poultry industries: surveys of backyard and gamefowl breeder flocks in the United States. Prev Vet Med (2007) 1.02
High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome. J Clin Oncol (1998) 1.02
Alopecia areata: an autoimmune disease? Exp Dermatol (1999) 1.01
Different populations of melanocytes are present in hair follicles and epidermis. Pigment Cell Res (1996) 1.01
Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis. Bone (1996) 1.00
Binding of antigen by immunocytes. I. Effect of ligand valence on binding affinity of MOPC 315 cells for DNP conjugates. J Exp Med (1973) 1.00
Modeling of facet articulation as a nonlinear moving contact problem: sensitivity study on lumbar facet response. J Biomech Eng (1998) 0.99
Increased types I and III collagen and transforming growth factor-beta 1 mRNA and protein in hypertrophic burn scar. J Invest Dermatol (1995) 0.99
Xanthogranuloma in adults. Arch Dermatol (1976) 0.99
Neuropathological studies on the toxic syndrome related to adulterated rapeseed oil in Spain. Brain (1983) 0.99
Transcriptome profiling of UPF3B/NMD-deficient lymphoblastoid cells from patients with various forms of intellectual disability. Mol Psychiatry (2011) 0.99
Differential effects of tobacco and alcohol in cancer of the larynx, pharynx, and mouth. Cancer (1986) 0.99
Adjuvant therapy of pemphigus. Arch Dermatol (1984) 0.99
Systemic neutrophil response resulting from dental plaque accumulation. J Periodontol (2001) 0.99
Limitations in the diagnosis of vesiculobullous diseases. Am J Dermatopathol (1983) 0.99
Antibodies against the cytoplasm of human epidermal cells. Arch Dermatol (1973) 0.98
Correlation between vitiligo antibodies and extent of depigmentation in vitiligo. J Am Acad Dermatol (1986) 0.97
Cytolytic antibodies to melanocytes in vitiligo. J Invest Dermatol (1993) 0.97
Identification and solubilization of iodinated cell surface human melanoma associated antigens. Int J Cancer (1977) 0.96
Using data mining to find fraud in HCFA health care claims. Top Health Inf Manage (2001) 0.96
Identification and purification of a Mr 75,000 cell surface human melanoma-associated antigen. Cancer Res (1982) 0.95
Fine-needle aspiration cytology and immunocytochemistry in the diagnosis of 24 gastrointestinal stromal tumors: a quick, reliable diagnostic method. Diagn Cytopathol (2003) 0.94
Risk factors for simultaneous carcinoma of the head and neck. Head Neck (1989) 0.94
Comparison of cell-surface human melanoma-associated antigens identified by rabbit and murine antibodies. Hybridoma (1982) 0.93
Regional variation in the expression of pemphigus foliaceus, pemphigus erythematosus, and pemphigus vulgaris antigens in human skin. J Invest Dermatol (1991) 0.93
Identification of pigment cell antigens defined by vitiligo antibodies. J Invest Dermatol (1992) 0.92
Scrub typhus in Korea: importance of early clinical diagnosis in this newly recognized endemic area. Mil Med (1993) 0.92
Morphometric studies of normal sural nerves in children. Muscle Nerve (1985) 0.91
Salt-induced hypertension in Dahl salt-sensitive rats. Hemodynamics and renal responses. Hypertension (1989) 0.91
Plasmapheresis and immunosuppressive therapy. Effect on levels of intercellular antibodies in pemphigus vulgaris. Arch Dermatol (1979) 0.91
Antibodies to melanocytes. Occurrence in patients with vitiligo and chronic mucocutaneous candidiasis. Arch Dermatol (1981) 0.90
Sex and the heart. Int J Impot Res (2005) 0.90
Characterization of thrombin receptor expression during vascular lesion formation. Circ Res (1994) 0.90
Hepatic resection for metastatic disease. Can J Surg (1986) 0.90
Therapeutic equivalence of three metered-dose inhalers containing salbutamol (Albuterol) in protecting against methacholine-induced bronchoconstriction in children with asthma. Pediatr Pulmonol (2001) 0.89